Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension
Clinical trial NCT05920005 · COMPLETED
Trial details
- NCT number
- NCT05920005
- Sponsor
- Hospital Israelita Albert Einstein
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2025-03-31
- Enrollment
- 702
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.